UNIVERSITIES and biotech companies are already jostling for a share of the $3 billion that California will put into stem cell research over the next 10 years.
On 2 November 59 per cent of voters in the state backed Proposition 71, which authorises the sale of tax-free bonds by the state government to provide $295 million a year for 10 years for research on adult, umbilical and embryonic stem cells.
That figure dwarfs the $215 million spent on stem cell research by the National Institutes of Health last year, of which only $25 million went into experiments on the handful of embryonic stem cell lines approved for…
